Conversely, modalities that modulate TCTP could be a promising strategy in the therapeutics for systemic hypertension, hypertension-induced atherosclerosis, and cataracts, all of which are associated with Na,K-ATPase suppression. Here, TPT1 is linked to Hypertension.